• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部进展期直肠癌新辅助放化疗后行胸部和腹部 CT 再分期是否必要?

Is restaging with chest and abdominal CT scan after neoadjuvant chemoradiotherapy for locally advanced rectal cancer necessary?

机构信息

Department of Surgical Oncology, Erasmus MC, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.

出版信息

Ann Surg Oncol. 2013 Jan;20(1):155-60. doi: 10.1245/s10434-012-2537-6. Epub 2012 Aug 9.

DOI:10.1245/s10434-012-2537-6
PMID:22875644
Abstract

BACKGROUND

There is no evidence regarding restaging of patients with locally advanced rectal cancer after a long course of neoadjuvant radiotherapy with or without chemotherapy. This study evaluated the value of restaging with chest and abdominal computed tomographic (CT) scan after radiotherapy.

METHODS

Between January 2000 and December 2010, all newly diagnosed patients in our tertiary referral hospital, who underwent a long course of radiotherapy for locally advanced rectal cancer, were analyzed. Patients were only included if they had chest and abdominal imaging before and after radiotherapy treatment.

RESULTS

A total of 153 patients who met the inclusion criteria and were treated with curative intent were included. A change in treatment strategy due to new findings on the CT scan after radiotherapy was observed in 18 (12%) of 153 patients. Twelve patients (8%) were spared rectal surgery due to progressive metastatic disease.

CONCLUSIONS

Restaging with a chest and abdominal CT scan after radiotherapy for locally advanced rectal cancer is advisable because additional findings may alter the treatment strategy.

摘要

背景

对于接受长程新辅助放化疗或单纯放疗的局部晚期直肠癌患者,目前尚无关于其后续再分期的证据。本研究旨在评估放疗后行胸部和腹部 CT 扫描再分期的价值。

方法

在 2000 年 1 月至 2010 年 12 月期间,对在我院接受长程放疗的所有新诊断局部晚期直肠癌患者进行了分析。只有在放疗前后均行胸部和腹部影像学检查的患者才被纳入。

结果

共纳入了 153 例符合纳入标准且接受根治性治疗的患者。在这 153 例患者中,有 18 例(12%)因放疗后 CT 扫描的新发现而改变了治疗策略。由于进展性转移疾病,12 例患者(8%)避免了直肠手术。

结论

对于局部晚期直肠癌患者,在放疗后行胸部和腹部 CT 扫描再分期是合理的,因为额外的发现可能会改变治疗策略。

相似文献

1
Is restaging with chest and abdominal CT scan after neoadjuvant chemoradiotherapy for locally advanced rectal cancer necessary?局部进展期直肠癌新辅助放化疗后行胸部和腹部 CT 再分期是否必要?
Ann Surg Oncol. 2013 Jan;20(1):155-60. doi: 10.1245/s10434-012-2537-6. Epub 2012 Aug 9.
2
Is follow-up CT imaging of the chest and abdomen necessary after preoperative neoadjuvant therapy in rectal cancer patients without evidence of metastatic disease at diagnosis?直肠癌患者术前新辅助治疗后无诊断转移证据时,是否需要进行胸部和腹部的随访 CT 成像?
Colorectal Dis. 2013 Nov;15(11):e654-8. doi: 10.1111/codi.12372.
3
Consequence of restaging after neoadjuvant treatment for locally advanced rectal cancer.局部晚期直肠癌新辅助治疗后重新分期的结果。
Ann Surg Oncol. 2015 Feb;22(2):552-6. doi: 10.1245/s10434-014-3996-8. Epub 2014 Aug 26.
4
Efficacy and safety of neoadjuvant intensity-modulated radiotherapy with concurrent capecitabine for locally advanced rectal cancer.新辅助调强放疗联合卡培他滨治疗局部晚期直肠癌的疗效与安全性
Dis Colon Rectum. 2015 Feb;58(2):186-92. doi: 10.1097/DCR.0000000000000294.
5
Routine preoperative restaging CTs after neoadjuvant chemoradiation for locally advanced rectal cancer are low yield: a retrospective case study.新辅助放化疗后局部晚期直肠癌常规术前分期 CT 检查的收益较低:一项回顾性病例研究。
Int J Surg. 2014 Dec;12(12):1295-9. doi: 10.1016/j.ijsu.2014.10.033. Epub 2014 Nov 4.
6
The Value of Restaging With Chest and Abdominal CT/MRI Scan After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.新辅助放化疗后胸部和腹部CT/MRI扫描对局部晚期直肠癌进行再分期的价值
Medicine (Baltimore). 2015 Nov;94(47):e2074. doi: 10.1097/MD.0000000000002074.
7
Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy.局部进展期直肠癌患者术前接受放化疗和辅助化疗后复发的预后因素。
Dis Colon Rectum. 2013 Apr;56(4):416-21. doi: 10.1097/DCR.0b013e318274d9c6.
8
Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial.新辅助卡培他滨联合标准放疗用于局部晚期直肠癌患者:一项II期试验的成熟结果
Strahlenther Onkol. 2008 Sep;184(9):450-6. doi: 10.1007/s00066-008-1751-4. Epub 2008 Sep 19.
9
Adjuvant treatment for locally advanced rectal cancer patients after preoperative chemoradiotherapy: when, and for whom?局部晚期直肠癌患者术前放化疗后的辅助治疗:时机及适用人群?
Clin Colorectal Cancer. 2014 Sep;13(3):185-91. doi: 10.1016/j.clcc.2014.05.004. Epub 2014 Jun 26.
10
[Preoperative diagnostic procedures in locally advanced rectal carcinoma (> or =T3 or N+). What does endoluminal ultrasound achieve at staging and restaging (after neoadjuvant radiochemotherapy) in contrast to computed tomography?].[局部进展期直肠癌(≥T3 或 N+)的术前诊断程序。与计算机断层扫描相比,腔内超声在分期及新辅助放化疗后的再分期中能达到什么效果?]
Chirurg. 2003 Mar;74(3):224-34. doi: 10.1007/s00104-002-0609-z.

引用本文的文献

1
Rationale and design of a prospective, multicenter, phase II clinical trial of safety and efficacy evaluation of long course neoadjuvant chemoradiotherapy plus tislelizumab followed by total mesorectal excision for locally advanced rectal cancer (NCRT-PD1-LARC trial).一项关于长疗程新辅助放化疗联合替雷利珠单抗随后行全直肠系膜切除术治疗局部晚期直肠癌安全性和疗效评估的前瞻性、多中心、II期临床试验的原理与设计(NCRT-PD1-LARC试验)
BMC Cancer. 2022 Apr 27;22(1):462. doi: 10.1186/s12885-022-09554-9.
2
Restaging Patients with Rectal Cancer Following Neoadjuvant Chemoradiation: A Systematic Review.新辅助放化疗后直肠癌患者再分期:系统评价。
World J Surg. 2020 Mar;44(3):973-979. doi: 10.1007/s00268-019-05309-z.
3
Early Systemic Failure After Preoperative Chemoradiotherapy for the Treatment of Patients With Rectal Cancer.
直肠癌患者术前放化疗后的早期全身功能衰竭
Ann Coloproctol. 2019 Apr;35(2):94-99. doi: 10.3393/ac.2018.08.28. Epub 2019 Apr 30.
4
Restaging Abdominopelvic Computed Tomography Before Surgery After Preoperative Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer.局部进展期直肠癌患者术前放化疗后手术前再次行全腹盆腔 CT 检查。
JAMA Oncol. 2018 Feb 1;4(2):259-262. doi: 10.1001/jamaoncol.2017.4596.
5
Rectal cancer restaging after neoadjuvant chemoradiation: towards a down-staging score system.新辅助放化疗后直肠癌再分期:迈向降期评分系统
J Gastrointest Oncol. 2017 Feb;8(1):187-188. doi: 10.21037/jgo.2016.10.04.
6
Restaging after neoadjuvant chemoradiation in rectal cancers: is histology the key in patient selection?直肠癌新辅助放化疗后的再分期:组织学是患者选择的关键吗?
J Gastrointest Oncol. 2016 Jun;7(3):360-4. doi: 10.21037/jgo.2016.01.08.
7
The Value of Restaging With Chest and Abdominal CT/MRI Scan After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.新辅助放化疗后胸部和腹部CT/MRI扫描对局部晚期直肠癌进行再分期的价值
Medicine (Baltimore). 2015 Nov;94(47):e2074. doi: 10.1097/MD.0000000000002074.